Amiodarone: reminder of risks of treatment and need for patient monitoring and supervision

• Amiodarone carries serious risks of pulmonary, hepatic, and thyroid toxicity requiring regular patient monitoring and supervision throughout treatment
• Healthcare professionals must ensure appropriate baseline investigations and regular follow-up assessments to detect potentially life-threatening adverse effects early
• Patient review protocols should be established and maintained to minimise harm and manage the recognised risks associated with amiodarone therapy

Amiodarone has been associated with serious and potentially life-threatening side effects, particularly of the lung, liver, and thyroid gland. We remind healthcare professionals that patients should be supervised and reviewe…

ClinicaliQ summarises and contextualises external updates for clinical awareness, then links to the original publisher for the full article and most current context.